These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis. Jung-Cook H Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156 [TBL] [Abstract][Full Text] [Related]
44. Seizure and radiological outcomes in children with solitary cysticercous granulomas with and without albendazole therapy: a retrospective case record analysis. Gulati S; Jain P; Sachan D; Chakrabarty B; Kumar A; Pandey RM; Gupta AK Epilepsy Res; 2014 Sep; 108(7):1212-20. PubMed ID: 24908563 [TBL] [Abstract][Full Text] [Related]
45. Clinical aspects of neurocysticercosis in children. Morales NM; Agapejev S; Morales RR; Padula NA; Lima MM Pediatr Neurol; 2000 Apr; 22(4):287-91. PubMed ID: 10788745 [TBL] [Abstract][Full Text] [Related]